FSA Wealth Management’s Gilead Sciences GILD Stock Holding History

FSA Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$26.6K	Buy	240 +10	+4%	+$1.14K	0.01%	216
2025 Q2	$25.5K	Hold	230	–	–	0.01%	215
2025 Q1	$25.8K	Hold	230	–	–	0.01%	200
2024 Q4	$21.2K	Hold	230	–	–	0.01%	227
2024 Q3	$19.3K	Buy	+230	New	+$17.6K	0.01%	245
2024 Q1	$14.7K	Hold	200	–	–	0.01%	286
2023 Q4	$16K	Buy	+200	New	+$15.6K	0.01%	260
2021 Q1	–	Sell	-200	Closed	-$12K	–	124
2020 Q4	$12K	Buy	+200	New	+$12.1K	0.01%	245
2020 Q3	–	Sell	-200	Closed	-$15K	–	168
2020 Q2	$15K	Hold	200	–	–	0.01%	221
2020 Q1	$15K	Buy	200 +100	+100%	+$6.91K	0.01%	203
2019 Q4	$6K	Buy	+100	New	+$6.51K	﹤0.01%	373

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

FSA Wealth Management's GILD Position: Q3 2025 in Review

FSA Wealth Management increased its Gilead Sciences (GILD) stake by 4.3% in Q3 2025, buying an estimated $1.14K and bringing the position to 240 shares worth $26.6K. The position accounts for 0.01% of the portfolio, ranked #216.

FSA Wealth Management first reported a position in GILD in Q4 2019 and has held it in 11 quarters since. 2,026 funds tracked by Wall St. Rank hold GILD as of Q3 2025.

FSA Wealth Management held 240 shares of Gilead Sciences worth $26.6K as of Q3 2025.
FSA Wealth Management bought 10 Gilead Sciences shares in Q3 2025, an estimated $1.14K.
Gilead Sciences made up 0.01% of FSA Wealth Management's portfolio in Q3 2025, its #216 holding.
FSA Wealth Management first reported a position in Gilead Sciences in Q4 2019 and has held it in 11 quarters since.
2,026 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2025.

Based on FSA Wealth Management's 13F filing for Q3 2025, filed 17 Nov 2025.